Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine monohydrate in depressed female methamphetamine users
NCT02189915Terminated
- Start
- Jan 2012
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of creatine in major depressive disorder (MDD) and methamphetamine use disorder (MUD). Primary endpoint: Hamilton Depression Rating Scale / Children Depression Rating Scale at 8 weeks. Started Jan 2012; status: terminated.
02
Drugs
creatine
03
Conditions
major depressive disorder (MDD)methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT02189915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02189915.